Completed OBSERVATIONAL NCT02998619

Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis

Retrospektive Analyse Der Radiotherapie Des Pelvinen Lymphabflusses Beim Lokalisierten Prostatakarzinom Vom Hochrisikotyp Anhand Der Klinikdatenbank 2010-2016

Sponsor: Kantonsspital Graubuenden

Conditions Lymph Node Disease Prostatic Neoplasms Benign Radiotherapy Side Effect

Interventions Radiotherapy

Updated 8 times since 2017 Last updated: Jul 27, 2018 Started: Dec 31, 2016 Primary completion: Nov 11, 2017 Completion: Jun 19, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02998619, this observational or N/A phase trial focuses on Lymph Node Disease and Prostatic Neoplasms Benign and remains completed. Sponsored by Kantonsspital Graubuenden, it has been updated 8 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Study Description(click to expand)

Collection of data and retrospective analysis of patients with high risk prostate cancer treated with radiotherapy to pelvic lymph nodes. What influence has irradiation of pelvic lymph nodes on patients with high risk prostate cancer in terms of progression free survival and toxicity. How does this influence side effects with respect to gastrointestinal (proctitis, abdominal pain, diarrhea) and genitourinary (cystitis, urinary disorders) toxicities (CTCAE v4.03)

Collection of data and retrospective analysis of patients with high risk prostate cancer treated with radiotherapy to pelvic lymph nodes.

What influence has irradiation of pelvic lymph nodes on patients with high risk prostate cancer in terms of progression free survival and toxicity. How does this influence side effects with respect to gastrointestinal (proctitis, abdominal pain, diarrhea) and genitourinary (cystitis, urinary disorders) toxicities (CTCAE v4.03)

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed
Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Aug 2018 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Aug 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kantonsspital Graubuenden

Data source: Kantonsspital Graubuenden

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chur, Switzerland